← All Sponsors

SPONSOR

Peking University People's Hospital

Total Trials

12

Recruiting

12

Phases

Phase 1, Phase 2, Phase 1, Phase 2, Phase 3, Phase 2

Conditions studied: Graft Failure Stem Cell Transplant Complications HER2-positive Early Breast Cancer AL Amyloidosis CD7+ T-ALL/LBL Multiple Myeloma, Newly Diagnosed Newly Diagnosed Multiple Myeloma (NDMM)Systemic Lupus Erythematosus Inflammatory Myopathy Systemic Sclerosis (SSc)

Second Haplo-transplantation for Graft Failure

NCT04750122 Phase 1, Phase 2

Neoadjuvant Therapy Study Guided by Drug Screening in Vitro for HER2 Positive Early Breast Cancer Patients

HER2-positive Early Breast Cancer

Prospective Study of Teclistamab in the Treatment of Systemic AL Amyloidosis

NCT07280494 Phase 1

To Observe the CD7-targeted CAR-T Therapy in the Treatment of MRD Positive T-ALL/LBL Post Allo-HSCT

NCT06879379 Phase 2, Phase 3

KPD Consolidation After ASCT in NDMM Patients

Multiple Myeloma, Newly Diagnosed

Real-world Immuno-therapy in Chinese Newly Diagnosed Multiple Myeloma Patients

Newly Diagnosed Multiple Myeloma (NDMM)

NCT06794008 Phase 2

BCMA-CD19 CAR-T Therapy for Refractory Autoimmune Diseases

Systemic Lupus Erythematosus

A Cohort Study of Combined Cryoablation and Thermal Ablation for Non-surgical Treatment of Breast Cancer Patients

Effects of Chinese Medicine and Lactobacillus in Persistent HPV Infection

Human Papilloma Virus Infection

Narlumosbartmab Combined With Neoadjuvant Chemotherapy in Bone-derived Malignancies With Osteolytic Lesions and Multinucleated Giant Cells

Malignant Bone Tumor

Fertility-sparing Therapy for Patients With Stage IA Endometrial Cancer

Endometrial Neoplasms

NCT07479732 Phase 1, Phase 2

Apatinib Combined With Liposomal Irinotecan for Refractory or Metastatic Osteosarcoma